Abstract:Objective To investigate the clinical effect of Bivalirudin in the treatment of acute myocardial infarction with cardiovascular intervention.Methods A total of 100 patients with acute myocardial infarction admitted to our hospital from August 2016 to August 2017 were selected as the study subjects.The patients were divided into control group and experimental group.There were 50 patients in each group.Patients received common heparin for anticoagulant therapy,meanwhile patients in the experimental group took bivalirudin for anticoagulant therapy.The surgical data,TIMI flow improvement,and postoperative MACE bleeding were compared between the two groups.Results There was no significant difference in the surgical data between the two groups(P>0.05).The TIMI blood flow improvement in the experimental group was better than that in the control group,the difference was statistically significant(P<0.05).The incidence of MACE and bleeding within 30 days after surgery were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion The treatment of patients with acute myocardial infarction who received Bivalirudin combined with cardiovascular intervention has achieved significant therapeutic effect,with high safety,and it is worthy of being more widely used in clinical practice.
范爱德. 比伐卢定在心血管介入治疗急性心肌梗死中的临床效果[J]. 中国当代医药, 2018, 25(28): 52-54.
FAN Ai-de. Clinical effect of Bivalirudin in the treatment of acute myocardial infarction with cardiovascular intervention. 中国当代医药, 2018, 25(28): 52-54.